Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement from the American Heart Association and American College of Cardiology

Circulation

Volumn 132, Issue 22, 2015, Pages e303-e309

  Braverman, Alan C ^a   Harris, Kevin M ^b   Kovacs, Richard J ^c   Maron, Barry J ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

AHA Scientific Statements; aortic diseases; athletes; bicuspid aortic valve; familial thoracic aortic aneurysm; Marfan syndrome

Indexed keywords

AORTA ANEURYSM; AORTA DISEASE; AORTA DISSECTION; AORTA ROOT; AORTA RUPTURE; ARTICLE; ASCENDING AORTA; ATHLETE; HUMAN; LOEYS DIETZ SYNDROME; MARFAN SYNDROME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; ADVISORY COMMITTEE; AORTIC DISEASES; BODY HEIGHT; CARDIOLOGY; CARDIOVASCULAR ABNORMALITIES; MEDICAL SOCIETY; PHYSIOLOGY; PRACTICE GUIDELINE; PROCEDURES; STANDARDS; UNITED STATES;

ADVISORY COMMITTEES; AMERICAN HEART ASSOCIATION; AORTIC DISEASES; ATHLETES; BODY HEIGHT; CARDIOLOGY; CARDIOVASCULAR ABNORMALITIES; HUMANS; MARFAN SYNDROME; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 84949314520     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000243     Document Type: Article

References (32)

1. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119:1085-1092. doi: 10.1161/CIRCULATIONAHA.108.804617.
2. Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewicz DM, Pyeritz RE, Sponseller PD, Wordsworth P, De Paepe AM. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47:476-485. doi: 10.1136/jmg.2009.072785.
3. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, Roberts AE, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006;355:788-798. doi: 10.1056/NEJMoa055695.
4. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW, Milewicz DM, Reich DL, Sen S, Shinn JA, Svensson LG, Williams DM. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine [published correction appears in Circulation. 2010;122:e410]. Circulation. 2010;121:e266-e369. doi: 10.1161/CIR.0b013e3181d4739e.
5. Milewicz DM, Regalado ES, Guo DC. Treatment guidelines for thoracic aortic aneurysms and dissections based on the underlying causative gene. J Thorac Cardiovasc Surg. 2010;140(suppl):S2-S4. doi: 10.1016/j.jtcvs.2010.07.027.
6. Braverman AC. Aortic involvement in patients with a bicuspid aortic valve. Heart. 2011;97:506-513. doi: 10.1136/hrt.2009.183871.
7. Michelena HI, Khanna AD, Mahoney D, Margaryan E, Topilsky Y, Suri RM, Eidem B, Edwards WD, Sundt TM 3rd, Enriquez-Sarano M. Incidence of aortic complications in patients with bicuspid aortic valves. JAMA. 2011;306:1104-1112. doi: 10.1001/jama.2011.1286.
8. Devereux RB, de Simone G, Arnett DK, Best LG, Boerwinkle E, Howard BV, Kitzman D, Lee ET, Mosley TH Jr, Weder A, Roman MJ. Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons ?15 years of age. Am J Cardiol. 2012;110:1189-1194. doi: 10.1016/j.amjcard.2012.05.063.
9. Biaggi P, Matthews F, Braun J, Rousson V, Kaufmann PA, Jenni R. Gender, age, and body surface area are the major determinants of ascending aorta dimensions in subjects with apparently normal echocardiograms. J Am Soc Echocardiogr. 2009;22:720-725. doi: 10.1016/j.echo.2009.03.012.
10. Roman MJ, Devereux RB, Kramer-Fox R, O'Loughlin J. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol. 1989;64:507-512.
11. Colan SD, McElhinney DB, Crawford EC, Keane JF, Lock JE. Validation and re-evaluation of a discriminant model predicting anatomic suitability for biventricular repair in neonates with aortic stenosis. J Am Coll Cardiol. 2006;47:1858-1865. doi: 10.1016/j.jacc.2006.02.020.
12. Chubb H, Simpson JM. The use of Z-scores in paediatric cardiology. Ann Pediatr Cardiol. 2012;5:179-184. doi: 10.4103/0974-2069.99622.
13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463. doi: 10.1016/j.echo.2005.10.005.
14. Campens L, Demulier L, De Groote K, Vandekerckhove K, De Wolf D, Roman MJ, Devereux RB, De Paepe A, De Backer J. Reference values for echocardiographic assessment of the diameter of the aortic root and ascending aorta spanning all age categories. Am J Cardiol. 2014;114:914-920. doi: 10.1016/j.amjcard.2014.06.024.
15. D'Andrea A, Cocchia R, Riegler L, Scarafile R, Salerno G, Gravino R, Vriz O, Citro R, Limongelli G, Di Salvo G, Cuomo S, Caso P, Russo MG, Calabrò R, Bossone E. Aortic root dimensions in elite athletes. Am J Cardiol. 2010;105:1629-1634. doi: 10.1016/j.amjcard.2010.01.028.
16. Pelliccia A, Di Paolo FM, De Blasiis E, Quattrini FM, Pisicchio C, Guerra E, Culasso F, Maron BJ. Prevalence and clinical significance of aortic root dilation in highly trained competitive athletes. Circulation. 2010;122:698-706. doi: 10.1161/CIRCULATIONAHA.109.901074.
17. Pelliccia A, Di Paolo FM, Quattrini FM. Aortic root dilatation in athletic population. Prog Cardiovasc Dis. 2012;54:432-437. doi: 10.1016/j. pcad.2012.01.004.
18. Babaee Bigi MA, Aslani A. Aortic root size and prevalence of aortic regurgitation in elite strength trained athletes. Am J Cardiol. 2007;100:528-530. doi: 10.1016/j.amjcard.2007.02.108.
19. Iskandar A, Thompson PD. A meta-analysis of aortic root size in elite athletes. Circulation. 2013;127:791-798. doi: 10.1161/CIRCULATIONAHA. 112.000974.
20. Reed CM, Richey PA, Pulliam DA, Somes GW, Alpert BS. Aortic dimensions in tall men and women. Am J Cardiol. 1993;71:608-610.
21. Braverman AC. Medical management of thoracic aortic aneurysm disease. J Thorac Cardiovasc Surg. 2013;145(suppl):S2-S6. doi: 10.1016/j. jtcvs.2012.11.062.
22. Hatzaras I, Tranquilli M, Coady M, Barrett PM, Bible J, Elefteriades JA. Weight lifting and aortic dissection: more evidence for a connection. Cardiology. 2007;107:103-106. doi: 10.1159/000094530.
23. Harris KM, Tung M, Haas TS, Maron BJ. Under-recognition of aortic and aortic valve disease and the risk for sudden death in competitive athletes. J Am Coll Cardiol. 2015;65:860-862. doi: 10.1016/j.jacc.2014.09.094.
24. Parish LM, Gorman JH 3rd, Kahn S, Plappert T, St John-Sutton MG, Bavaria JE, Gorman RC. Aortic size in acute type A dissection: implications for preventive ascending aortic replacement. Eur J Cardiothorac Surg. 2009;35:941-945. doi: 10.1016/j.ejcts.2008.12.047.
25. Pape LA, Tsai TT, Isselbacher EM, Oh JK, O'Gara PT, Evangelista A, Fattori R, Meinhardt G, Trimarchi S, Bossone E, Suzuki T, Cooper JV, Froehlich JB, Nienaber CA, Eagle KA; International Registry of Acute Aortic Dissection (IRAD) Investigators. Aortic diameter ?5.5 cm is not a good predictor of type A aortic dissection: observations from the International Registry of Acute Aortic Dissection (IRAD). Circulation. 2007;116:1120-1127. doi: 10.1161/CIRCULATIONAHA.107.702720.
26. Engelfriet PM, Boersma E, Tijssen JG, Bouma BJ, Mulder BJ. Beyond the root: dilatation of the distal aorta in Marfan's syndrome. Heart. 2006;92:1238-1243. doi: 10.1136/hrt.2005.081638.
27. Mimoun L, Detaint D, Hamroun D, Arnoult F, Delorme G, Gautier M, Milleron O, Meuleman C, Raoux F, Boileau C, Vahanian A, Jondeau G. Dissection in Marfan syndrome: the importance of the descending aorta. Eur Heart J. 2011;32:443-449. doi: 10.1093/eurheartj/ehq434.
28. Kari FA, Fazel SS, Mitchell RS, Fischbein MP, Miller DC. Bicuspid aortic valve configuration and aortopathy pattern might represent different pathophysiologic substrates. J Thorac Cardiovasc Surg. 2012;144:516-517. doi: 10.1016/j.jtcvs.2012.05.035.
29. Maron BJ, Ackerman MJ, Nishimura RA, Pyeritz RE, Towbin JA, Udelson JE. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol. 2005;45:1340-1345. doi: 10.1016/j.jacc.2005.02.011.
30. Kinoshita N, Mimura J, Obayashi C, Katsukawa F, Onishi S, Yamazaki H. Aortic root dilatation among young competitive athletes: echocardiographic screening of 1929 athletes between 15 and 34 years of age. Am Heart J. 2000;139:723-728.
31. Bonow RO, Nishimura RA, Thompson PD, Udelson JE; on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and the American College of Cardiology. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 5: valvular heart disease: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e292-e297. doi: 10.1161/CIR.0000000000000241.
32. Levine BD, Baggish AL, Kovacs RJ, Link MS, Maron MS, Mitchell JH; on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and the American College of Cardiology. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 1: classification of sports: dynamic, static, and impact: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e262-e266. doi: 10.1161/CIR.0000000000000237.